CLSN [NASD]
Celsion Corporation
Index- P/E- EPS (ttm)-3.91 Insider Own0.40% Shs Outstand86.56M Perf Week-7.45%
Market Cap16.00M Forward P/E- EPS next Y-4.08 Insider Trans68.24% Shs Float80.36M Perf Month-27.16%
Income-20.80M PEG- EPS next Q-0.99 Inst Own9.70% Short Float0.22% Perf Quarter-57.93%
Sales0.50M P/S32.00 EPS this Y62.00% Inst Trans-2.81% Short Ratio0.53 Perf Half Y-79.14%
Book/sh9.66 P/B0.24 EPS next Y3.70% ROA-26.80% Target Price32.67 Perf Year-86.78%
Cash/sh7.29 P/C0.32 EPS next 5Y- ROE-35.50% 52W Range2.30 - 23.25 Perf YTD-70.86%
Dividend- P/FCF- EPS past 5Y53.60% ROI-35.40% 52W High-89.85% Beta2.28
Dividend %- Quick Ratio7.70 Sales past 5Y0.00% Gross Margin- 52W Low2.61% ATR0.26
Employees29 Current Ratio7.70 Sales Q/Q0.00% Oper. Margin- RSI (14)30.33 Volatility8.96% 8.65%
OptionableYes Debt/Eq0.11 EPS Q/Q38.40% Profit Margin- Rel Volume0.07 Prev Close2.34
ShortableYes LT Debt/Eq0.11 EarningsMay 16 BMO Payout- Avg Volume333.76K Price2.36
Recom2.50 SMA20-17.37% SMA50-40.40% SMA200-74.74% Volume22,469 Change0.85%
Jul-16-20Downgrade Oppenheimer Outperform → Perform
Jul-14-20Downgrade Dawson James Buy → Neutral
Oct-04-17Upgrade Maxim Group Hold → Buy $7
Apr-10-17Resumed Rodman & Renshaw Buy $1.50
Nov-10-16Downgrade Maxim Group Buy → Hold
Jul-12-16Resumed H.C. Wainwright Buy $3
Jan-19-16Reiterated Maxim Group Buy $12 → $9
Jul-15-15Initiated Maxim Group Buy $12
Jan-10-14Resumed HC Wainwright Buy $5 → $8
Aug-16-12Reiterated Griffin Securities Buy $10 → $18
Feb-16-12Initiated Brean Murray Buy $7
Oct-26-11Initiated Rodman & Renshaw Mkt Outperform $6
Nov-11-09Initiated Needham Buy $7
May-16-22 08:00AM  
May-10-22 08:30AM  
May-09-22 08:30AM  
Apr-21-22 03:24PM  
11:30AM  
Apr-14-22 08:30AM  
Apr-12-22 08:30AM  
Apr-08-22 04:30PM  
Apr-06-22 08:30AM  
08:30AM  
Apr-05-22 06:15AM  
Apr-01-22 08:00AM  
Mar-31-22 08:30AM  
Mar-24-22 09:00AM  
Feb-28-22 09:00AM  
08:30AM  
Feb-17-22 08:30AM  
Jan-31-22 08:00AM  
Jan-13-22 05:30PM  
Jan-10-22 08:45PM  
Nov-29-21 08:30AM  
Nov-17-21 07:25AM  
Nov-15-21 08:30AM  
Nov-09-21 09:00AM  
Nov-08-21 09:00AM  
08:30AM  
Oct-15-21 09:00AM  
Oct-12-21 09:00AM  
Oct-11-21 09:00AM  
08:09AM  
06:44AM  
Oct-05-21 09:00AM  
Sep-30-21 09:00AM  
Sep-17-21 09:00AM  
Sep-03-21 12:40PM  
Sep-02-21 10:02AM  
08:00AM  
Aug-14-21 05:02AM  
Aug-12-21 08:00AM  
Aug-05-21 08:00AM  
Jul-29-21 10:00AM  
Jul-19-21 08:00AM  
Jul-15-21 08:00AM  
Jul-14-21 09:11AM  
Jul-01-21 08:00AM  
Jun-23-21 08:00AM  
Jun-21-21 08:00AM  
Jun-11-21 08:30AM  
Jun-09-21 08:00AM  
Jun-08-21 08:00AM  
Jun-07-21 05:00PM  
Jun-04-21 10:11AM  
Jun-02-21 08:00AM  
May-27-21 08:30AM  
May-14-21 08:15AM  
08:00AM  
May-11-21 08:00AM  
May-07-21 08:30AM  
Apr-22-21 08:30AM  
Apr-05-21 05:00PM  
Apr-01-21 09:23AM  
08:30AM  
Mar-31-21 08:00AM  
Mar-19-21 09:15AM  
08:45AM  
Mar-12-21 08:45AM  
Mar-05-21 12:00PM  
08:32AM  
Mar-02-21 08:45AM  
Mar-01-21 12:46PM  
Feb-26-21 08:45AM  
Feb-25-21 07:26PM  
05:00PM  
04:10PM  
02:45PM  
11:34AM  
08:45AM  
Feb-23-21 08:00AM  
Feb-22-21 07:30AM  
05:17AM  
Feb-12-21 08:30AM  
03:43AM  
Feb-11-21 08:30AM  
Feb-09-21 08:00AM  
Feb-06-21 05:16PM  
Jan-29-21 08:32AM  
Jan-28-21 08:00AM  
Jan-26-21 05:00PM  
Jan-22-21 08:40AM  
Jan-21-21 11:53PM  
10:01AM  
08:47AM  
Dec-29-20 01:20PM  
10:30AM  
09:37AM  
09:10AM  
Dec-28-20 12:55PM  
09:24AM  
Dec-26-20 09:00AM  
Dec-24-20 05:02PM  
Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and vaccines. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for the treatment of primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product, which is in Phase II clinical trials for the localized treatment of ovarian cancers. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tardugno Michael HChairman, President and CEOApr 12Buy3.534,00014,12916,513Apr 12 02:19 PM
Fritz Frederick J.DirectorApr 08Buy4.055,00020,25011,766Apr 11 03:09 PM
Fritz Frederick J.DirectorMar 02Buy4.692,0009,3726,766Mar 03 12:49 PM
Fritz Frederick J.DirectorOct 07Buy0.8820,00017,60071,491Oct 08 08:50 AM